The number of people with susceptibility test result for rifampicin in India
India: The number of people with susceptibility test result for rifampicin was 76.27 in 2021. ▲ Rising
Latest (2021)
76.27
Change on year
down 22.0%
World rank
98th
of 146 countries
All-time high
97.76
in 2020
All-time low
31.17
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in India, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in India is 76.27, measured in 2021.
That represents a change of down 22.0% on the previous year and up 144.7% over five years.
That places India 98th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in India, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 31.17 | — |
| 2018 | 47.84 | +53.5% |
| 2019 | 76.91 | +60.8% |
| 2020 | 97.76 | +27.1% |
| 2021 | 76.27 | -22.0% |
India compared with similar countries
- India's 76.27 is below the median for lower middle income countries, which is 78.77, 97% of the median. (32 countries reporting)
- India's 76.27 is below the median for South Asia, which is 81.26, 94% of the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 51.98 | 31.17 | 76.91 | 3 |
| 2020s | 87.02 | 76.27 | 97.76 | 2 |
Countries ranked near India
More health data for India
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4372 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,332 deaths per 1,000 people (2090)
- Number of infants who die before age 1 44,822 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 38 (2025)
- Population ages 00-04, female, annual growth rate -0.3809 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0372 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5922 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in India?
- The number of people with susceptibility test result for rifampicin in India was 76.27 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in India?
- The highest recorded value was 97.76 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in India?
- The lowest recorded value was 31.17 in 2017.
- How does India rank for the number of people with susceptibility test result for rifampicin?
- India ranks 98th out of 146 countries with data for 2021.
- Where does this India data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).